|4Mar 18, 5:38 PM ET

Votruba Michal 4

4 · BioXcel Therapeutics, Inc. · Filed Mar 18, 2019

Insider Transaction Report

Form 4
Period: 2019-03-07
Transactions
  • Disposition to Issuer

    Stock Options (Right to Buy)

    2019-03-07$7.91/sh10,000$79,1000 total
    Exercise: $7.91Exp: 2029-03-07Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]The shares underlying this stock option vest as follows: one-third on each of 3/7/2020, 3/7/2021 and 3/7/2022, subject to the Reporting Person's continuous service to the Issuer through such dates.
  • [F2]The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of the Issuer with the permission of RSJ.

Documents

1 file
  • 4
    a4.xmlPrimary

    4